Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,584,692
+$1,713,679 QoQ
Shares Held
978,055
+40.0% QoQ
Ownership
0.478%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 216 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. ANNX ranks #55 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,584,692 | 978,055 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,871,013 | 698,739 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,880,214 | 573,748 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,248,904 | 409,477 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $904,736 | 376,974 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $671,430 | 347,892 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,209,422 | 235,755 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,291,826 | 218,214 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $738,018 | 150,616 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $207,248 | 28,905 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $74,600 | 16,432 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $26,474 | 11,218 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $61,181 | 17,381 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,066 | 277 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,406 | 272 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,643 | 266 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $652 | 173 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,750 | 2,839 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $161,112 | 14,022 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,065 | 111 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,498 | 111 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $109,216 | 3,923 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $293,526 | 11,727 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $334,464 | 11,064 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||